Involvement of Prostaglandin Synthase in the Metabolic Activation of Acetaminophen and Phenacetin

Davidson D, Eastham W: Acute liver necrosis following overdose of paracetamol. Brit Med J (2): 497–499, 1966.PubMedCrossRefGoogle Scholar

Brown RAG: Hepatic and renal damage with paracetamol overdosage. J Clin Pathol (21): 793, 1968.PubMedCrossRefGoogle Scholar

Boyer TD, Rouff SL: Acetaminophen-induced hepatic necrosis and renal failure. J Amer Med Assoc (218): 440–441, 1971.CrossRefGoogle Scholar

Proudfoot AT, Wright N: Acute paracetamol poisoning. Brit Med J (3): 557–558, 1970.PubMedCrossRefGoogle Scholar

Prescott LF, Wright N, Roscoe P, Brown SS: Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet (1): 519–522, 1971.PubMedCrossRefGoogle Scholar

Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB: Acetaminophen-induced hepatic necrosis II, Role of covalent binding in vivo. J Pharmacol Exp. Ther (187): 195–202, 1973.PubMedGoogle Scholar

Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB: Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (187): 185–194, 1973.PubMedGoogle Scholar

Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB: Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (187): 211–217, 1973.PubMedGoogle Scholar

Moldéus P: Paracetamol metabolism and toxicity in isolated hepatocytes from rat and mouse. Biochem Pharmacol (27): 2859–2863, 1978.PubMedCrossRefGoogle Scholar

McMurtry RJ, Snodgrass WR, Mitchell JR: Renal necrosis, glutathione depletion and covalent binding after acetaminophen. Toxicol Appl Pharmacol (46): 87–100, 1978.PubMedCrossRefGoogle Scholar

Gabriel R, Caldwell J, Hartley RB: Acute tubular necrosis, caused by therapeutic doses of paracetamol? Clin Nephr (18): 269–271, 1982.Google Scholar

Cobden I, Record CO, Ward MK, Kerr DNS: Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Brit Med J (284): 21–22, 1982.CrossRefGoogle Scholar

Prescott LF, Proudfoot AT, Creegen RJ: Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Brit Med J (284): 421–422, 1982.CrossRefGoogle Scholar

Duggin GG: Mechanisms in the development of analgesic nephropathy. Kidney Int (18): 553–561, 1980.PubMedCrossRefGoogle Scholar

Stewart JH: Analgesic abuse and renal failure in Australasia. Kidney Int (13): 72–78, 1978.PubMedCrossRefGoogle Scholar

Spühler O, Zollinger HV: Die chronische-interstitille Nephritis. Z Klin Med (151): 1–9, 1953.PubMedGoogle Scholar

Bengtsson U: A comparative study of chronic non-obstructive pyelonephritis and renal papillary necrosis. Acta Med Scand (Suppl) (388): 5–71, 1962.Google Scholar

Hultengren N, Lagergren C, Ljungqvist A: Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chir Scand (130): 314–320, 1965.Google Scholar

Johansson S, Wahlqvist, L: Tumorus of urinary bladder and ureter associated with abuse of phenacetin-containing analgesics. Acta Pathol Microbiol Scand Sect A (85): 768–774, 1977.Google Scholar

Isaka H, Yoshii H, Otsuji A, Koike M, Nagai Y, Koura M, Sugiyasu K, Kanabayaishi T: Tumors of Sprague-Dawley rats induced by long-term feeding of phenacetin. Gann (70): 29–36, 1979.PubMedGoogle Scholar

Johansson SL: Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetaminophen). Int J Cancer (27): 521–529, 1981.PubMedCrossRefGoogle Scholar

Smith RL, Timbrell JA: Factors affecting the metabolism of phenacetin. I. Influence of dose, chronic dosage, route of administration and species on the metabolism of (1–14C-acetyl)phenacetin. Xenobiotica (4): 489–501, 1974.PubMedCrossRefGoogle Scholar

Klutch A, Harfenist M, Conney AH: 2-hydroxy-acetophenetidine, a new metabolite of acetophenetidine. J Med Chem (9): 63–66, 1966.CrossRefGoogle Scholar

Nery R: Some new aspects of the metabolism of phenacetin in the rat. Biochem J (122): 317–326, 1971.PubMedGoogle Scholar

Calder IC, Creek MJ, Williams PJ, Funder CC, Green CR, Ham KN, Tange JD: N-hydroxylation of p-acetophenetidide as a factor in nephrotoxicity. J Med Chem (16): 499–502, 1973.PubMedCrossRefGoogle Scholar

Calder IC, Goss DE, Williams PJ, Funder CC, Green CR, Ham KN, Tange JD: Neoplasia in the rat induced by Nhydroxyphenacetin, a metabolite of phenacetin. Pathology (8): 1–6, 1976.PubMedCrossRefGoogle Scholar

Mulder GJ, Hinson JA, Gillette JR: Conversion of the N-Oglucuronide and N-O-sulfate conjugates of N-hydroxyphenacetin to reactive intermediates. Biochem Pharmacol (27): 1641–1649, 1978.PubMedCrossRefGoogle Scholar

Vaught JB, McGarvey PB, Lee M-S, Garner CD, Wang CY, Linsmaier-Bednar EM, King CM: Activation of N-hydroxyphenacetin to mutagenic and nucleic acid-binding metabolites by acyltransfer, deacylation and sulfate conjugation. Cancer Res (41): 3424–3429, 1981.PubMedGoogle Scholar

Wirth PJ, Dybing E, von Bahr C, Thorgeirsson SS: Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test-system. Metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster and man. Mol Pharmacol (18): 117–127, 1980.PubMedGoogle Scholar

Carpenter HM, Mudge GH: Acetaminophen nephrotoxicity: Studies on renal acetylation and deacetylation. J Pharmacol Exp Ther (218): 171–167, 1981.Google Scholar

Newton JF, Yoshimoto M, Bernstein J, Rush GF, Hook JB: Acetaminophen nephrotoxicity in the rat. II. Strain differences in nephrotoxicity and metabolism of p-aminophenol, a metabolite of acetaminophen. Toxicol Appl Pharmacol (69): 307–318, 1983.PubMedCrossRefGoogle Scholar

Zenser TV. Mattammal MB, Davis BB: Differential distribution of mixed function oxidase activities in rabbit kidney. J Pharmacol Exp Ther (207): 719–725, 1978.PubMedGoogle Scholar

Cavallo T: Fine structural localization of endogenous peroxidase activity in inner medullary interstitial cells of the rat kidney. Lab Invest (31): 458–464, 1974.PubMedGoogle Scholar

Smith WL, Wilkin GP: Immunochemistry of prostaglandin endoperoxide forming cyclooxygenases: The detection of the cyclooxygenases in rat, rabbit and guinea pig kidneys by immunofluorescence. Prostaglandins (13): 873–892, 1977.PubMedCrossRefGoogle Scholar

Samuelsson B, Goldyne M, Granström E, Hamberg M, Hammar-ström S, Malmsten C: Prostaglandins and thromboxanes. Ann Rev Biochem (47): 997–1029, 1978.PubMedCrossRefGoogle Scholar

Miyamoto T, Ogino N, Yamamoto S, Hayaishi O: Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J Biol Chem (251): 2629–2636, 1976.PubMedGoogle Scholar

O’Brien PJ, Rahimtula A: The possible involvement of a peroxidase in prostaglandin biosynthesis. Biochem Biophys Res Commun (70): 832–838, 1976.PubMedCrossRefGoogle Scholar

Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol) (231): 232–235, 1971.Google Scholar

Marnett LJ: Polycyclic aromatic hydrocarbon oxidation during prostaglandin biosynthesis. Life Sci (29): 531–546, 1981.PubMedCrossRefGoogle Scholar

Marnett LJ, Eling TE: Cooxidation during prostaglandin biosynthesis: A pathway for the metabolic activation of xenobiotics. In: Hodgson E, Bend JR, Philpot RM (ed) Reviews in Biochemical Toxicology 5. Elsevier Biomedical. New York, 1983, pp 135–172.Google Scholar

Eling T, Boyd J, Reed G, Mason R, Sivarajah K: Xenobiotic metabolism by prostaglandin endoperoxide synthetase. Drug Metab Rev (14): 219–248, 1983.CrossRefGoogle Scholar

Moldéus P, Rahimtula A: Metabolism of paracetamol to a glutathione conjugate catalyzed by prostaglandin synthetase. Biochem Biophys Res Commun (96): 469–475, 1980.PubMedCrossRefGoogle Scholar

Mohandas J, Duggin GG, Horvath JS, Tiller DJ: Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed-function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney. Toxicol Appl Pharmacol (61): 252–259, 1981.PubMedCrossRefGoogle Scholar

Boyd JA, Eling TE: Prostaglandin endoperoxide synthetasedependent cooxidation of acetaminophen to intermediates which covalently bind in vitro to rabbit renal medullary microsomes. J Pharmacol Exp Ther (219): 659–664, 1981.PubMedGoogle Scholar

Moldéus P, Andersson B, Rahimtula A, Berggren M: Prostaglandin synthetase catalyzed activation of paracetamol. Biochem Pharmacol (31): 1363–1368, 1982.PubMedCrossRefGoogle Scholar

Egan RW, Gale PH, Kuehl Jr FA: Reduction of hydroperoxides in the prostaglandin biosynthetic pathway by a microsomal peroxidase. J Biol Chem (254): 3295–3302, 1979.PubMedGoogle Scholar

Zenser TV, Mattammal MB, Herman CA, Joshi S, Davis BB: Effect of acetaminophen on prostaglandin E2 and prostaglandin F2a synthesis in the renal inner medulla of rat. Biochim Biophys Acta (542): 486–495, 1978.PubMedGoogle Scholar

Egan RW, Paxton J, Kuehl Jr FA: Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem (251): 7329–7335, 1976.PubMedGoogle Scholar

Jollow DJ, Thorgeirsson SS, Potter WZ, Hashimoto M, Mitchell JR: Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and non-toxic doses of acetaminophen. Pharmacology (12): 251–271, 1974.PubMedCrossRefGoogle Scholar

Hinson JA, Pohl LR, Monks TJ, Gillette JR: Acetaminophen-induced hepatotoxicity. Life Sci (29): 107–116, 1981.PubMedCrossRefGoogle Scholar

Corcoran GB, Mitchell JR, Vaishnav YN, Horning EC: Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinone-imine. Mol Pharmacol (18): 536–542, 1980.PubMedGoogle Scholar

Nelson SD, Dahlin DC, Rauchman EJ, Rosen GM: Peroxidasemediated formation of reactive metabolites of acetaminophen. Mol Pharmacol (20): 195–199, 1981.PubMedGoogle Scholar

Ohnishi T, Yamazaki H, Iyanagi T, Nakamura T, Yamasaki I: One-electron-transfer reactions in biological systems. II. The reaction of free radicals formed in the enzymatic oxidation. Biochim Biophys Acta (172): 357–369, 1969.PubMedCrossRefGoogle Scholar

deVries J: Hepatotoxic metabolic activation of paracetamol and its derivatives phenacetin and benorilate: oxygenation or electron transfer? Biochem Pharmacol (30): 399–402, 1981.CrossRefGoogle Scholar

Duggin GG, Mudge GH: Analgesic nephropathy: Renal distribution of acetaminophen and its conjugates. J Pharmacol Exp Ther (199): 1–9, 1976.PubMedGoogle Scholar

Andersson B, Nordenskjöld M, Rahimtula A, Moldéus P: Prostaglandin synthetase-catalyzed activation of phenacetin metabolites to genotoxic products. Mol Pharmacol (22): 479–485, 1982.PubMedGoogle Scholar

Josephy PD, Eling TE, Mason RP: An electron spin resonance study of the activation of benzidine by peroxidases. Mol Pharmacol (23): 766–770, 1983.PubMedGoogle Scholar

Andersson B, Larsson R, Rahimtula A, Moldéus P: Hydroperoxide-dependent activation of p-phenetidine catalyzed by prostaglandin synthase and other peroxidases. Biochem Pharmacol (32): 1045–1050, 1983.PubMedCrossRefGoogle Scholar

Andersson B, Larsson R, Rahimtula A, Moldéus P: Prostaglandin synthase and horseradish peroxidase catalyzed DNA-binding of p-phenetidine. Carcinogenesis (5): 161–165, 1984.PubMedCrossRefGoogle Scholar

Baud L, Nivez M-P, Chansel D, Ardaillou R: Stimulation by oxygen radicals of prostaglandin production by rat renal glomeruli. Kidney Int (20): 332–339, 1981.PubMedCrossRefGoogle Scholar

Griffin BW, Ting PL: Mechanism of N-demethylation of aminopyrene by hydrogen peroxide catalyzed by horseradish peroxide, metmyoglobin and protohemin. Biochemistry (17): 2206–2211, 1978.PubMedCrossRefGoogle Scholar

Harnett LJ, Siedlik PH, Fung LWM: Oxidation of phenidene and BW 755 C by prostaglandin endoperoxide synthetase. J Biol Chem (257): 6957–6964, 1982.Google Scholar

Josephy PD, Eling T, Mason RP: An electron spin resonance study of the activation of benzidine by peroxidases. Mol Pharmacol (23): 766–770, 1983.PubMedGoogle Scholar

Josephy PD, Eling T, Mason RP: The horseradish peroxidase catalyzed oxidation of 3,5,3’,5’-tetramethylbenzidine:free radical and charge transfer complex intermediates. J Biol Chem (257): 3669–3675, 1982.PubMedGoogle Scholar

Josephy PD, Eling T, Mason RP: Cooxidation of the clinical reagent 3,5,3’,5’-tetramethylbenzidine by prostaglandin synthase. Cancer Res (42): 2567–2570, 1982.PubMedGoogle Scholar

Ross D, Larsson R, Andersson B, Nilsson U, Lindqvist T, Lindeke B, Moldéus P: The oxidation of p-phenetidine by horse radish peroxidase and prostaglandin synthase and the fate of glutathione during such reactions. Biochem Pharmacol, In press, 1984/1985.Google Scholar

Moldéus P, O’Brien PJ, Thor H, Berggren M, Orrenius S: Oxidation of glutathione by free radical intermediates formed during peroxidase-catalyzed N-demethylation reactions. FEBS Lett (162): 411–415, 1983.Google Scholar

Moldéus P, Jernström B: Interaction of glutathione with reactive intermediates. In: Larsson A, Orrenius S, Holmgren A, Mannervik B (eds). Functions of glutathione. Biochemical, Physiological Toxicological and Clinical Aspects. Raven Press, New York, 1983, pp 99–108.Google Scholar

Schafer K, Bonfacic M, Bahnemann D, Asmus KO: Addition of oxygen to organic sulfur radicals. J Phys Chem (82): 2777–2780, 1978.CrossRefGoogle Scholar

Quintilliani M, Badiello R, Tamba M, Esfandi A, Gorin G: Radiolysis of glutathione in oxygen-containing solutions of pH 7. Int J Radiat Biol (32): 195–202, 1977.CrossRefGoogle Scholar

Quintilliani M, Badiello R, Tamba M, Gorin G: Radiation chemical basis for the role of glutathione in cellular radiation sensitivity. In: Modification of radiosensitivity of biological systems. Vienna IAEA, 1976, pp 2937Google Scholar

Saunders BC: Peroxidases and catalases. In: Eichhorn GL (ed). Inorganic Biochemistry 2. Elsevier, New York, 1973, pp 988–1021.Google Scholar

Parker VD: Anodic oxidation of amines. In: Baizer MM (ed). Organic electrochemistry. Marcel-Dekker Inc., New York, 1973, pp 509–529.Google Scholar

Larsson R, Ross D, Rahimtula A, Norbeck K, Lindeke B. Moldéus P: Reactive products formed by peroxidase catalyzed oxidation of p-phenetidine. Chem Biol Interactions, In press, 1984.Google Scholar

Ross D, Larsson R, Norbeck K, Ryhage R, Moldéus P: Characterization and mechanism of formation of reactive products formed during peroxidase catalyzed oxidation of p-phenetidine: trapping of reactive species using reduced glutathione and butylated hydroxyanisole. Molec Pharmacol, In press, 1984.Google Scholar

Claiborne A, Fridovich I: Chemical and enzymatic intermediates in the peroxidation of o-dianisidine by horseradish peroxidase. I. Spectral properties of the products of dianisidine oxidation. Biochemistry (18): 2324–2329, 1979.PubMedCrossRefGoogle Scholar

Oldfield LF, Bockris JO’M: Reversible oxidation-reduction reactions of aromatic amines. J Phys Colloid Chem (55): 1255–1274, 1951.CrossRefGoogle Scholar

Josephy PD, Van Dame A: Reaction of 4-substituted phenols with benzidine in a peroxidase system. Biochem Pharmacol, submitted, 1983.Google Scholar

Larsson R, Andersson B, von Bahr C, Berlin T, Moldéus P: Prostaglandin synthase catalyzed metabolic activation of p-phenetidine in the human kidney medulla. Biochem Pharmacol, submitted, 1983.Google Scholar

Saker BM, Kincaid-Smith P: Papillary necrosis in experimental analgesic nephropathy. Brit Med J (1): 161–162, 1969.PubMedCrossRefGoogle Scholar